Document:

EX-10.24

 Exhibit 10.24 

March 28, 2014 
 Subject to execution by the Company below,
this letter shall constitute my notice of resignation from my employment at Accretive Health, Inc., (the “Company”), including my resignation from my position with the Company of Senior Vice President, Provider Solutions, in each
case effective as of April 11, 2014. 
 By executing below, the Company agrees that, for purposes of my Employment Agreement with the Company, dated as
of June 17, 2005, as amended by that certain letter agreement dated September 24, 2009 (as so amended, the “Employment Agreement”), my resignation shall be deemed to be a termination of my employment pursuant to clause
(ii) of Section 9(a) of my Employment Agreement (the “Relevant Separation Provision”). For the avoidance of doubt, upon my resignation, I shall continue to be entitled to the benefits set forth in Section 9 of my
Employment Agreement (including any such benefits related to salary continuation) in accordance with the terms and conditions thereof to the same extent that I would be entitled to such benefits if my separation from the Company occurred pursuant to
the Relevant Separation Provision. 
 Those sections of the Employment Agreement which, by their terms, are intended to survive the Term (as defined in the
Employment Agreement) shall remain in full force and effect in accordance with their respective terms. 
 As of the date hereof, the Indemnification
Agreement, dated as of April 23, 2010, by and between the Company and myself (the “Indemnification Agreement”), is in full force and effect in accordance with its terms, and the Indemnification Agreement shall not terminate as
a result of my resignation from the Company described above. 
 Additionally, the period during which I may exercise my options to purchase common stock of
the Company that have vested as of the effective date of my resignation shall continue until the earlier of (i) the date that is the last day of the first consecutive sixty day period beginning after the date hereof during which the Company has
on file with the Securities and Exchange Commission an effective (i.e., not suspended) registration statement on form S-8 covering the issuance of shares upon such exercise and (ii) the expiration of such options; provided, however, that
nothing herein shall be deemed to permit my exercise of any such options to the extent such exercise is not otherwise permitted pursuant to the terms of the Company’s Amended and Restated Stock Option Plan, as amended or the Company’s 2010
Stock Incentive Plan, as applicable. The Company acknowledges that, as of the date hereof, I hold outstanding vested stock options, granted pursuant to stock option award agreements entered into under the Company’s equity compensation plans, to
purchase (i) an aggregate of 781,236 shares of common stock of the Company at an exercise price of $0.77 per share (which options expire on September 1, 2015) and (ii) an aggregate of 450,800 shares of common stock of the Company at
an exercise price of $14.71 per share (which options expire on February 3, 2020). I acknowledge that, except for the foregoing stock options, I do not have any other rights with respect to any compensatory equity awards in the Company or its
affiliates; provided that nothing contained herein shall be construed as a waiver in any respect of any rights that I have with respect to any vested shares of common stock of the Company. 

 In the event of any dispute between me and the Company arising out of this resignation letter which cannot be
settled amicably, such dispute shall be resolved through arbitration in accordance with the procedures set forth in Section 17 of the Employment Agreement. 

 

	
	 /s/ John Staton

	John Staton

  

	
	Acknowledged and agreed to on this
	 28th day of March, 2014 by:

Accretive Health, Inc.

	By: /s/ Daniel
Zaccardo                                        

	Name: Daniel
Zaccardo                                        

	Title: SVP/General
CounselEX-10.25

 Exhibit 10.25 

ACCRETIVE HEALTH, INC. 
 401
N. Michigan Avenue 
 Suite 2700 

Chicago, Illinois 60611 
 April 29, 2014 

Mr. Joseph Flanagan 
  

	Re:	Amendment to Offer Letter 

 Dear Joe: 

Reference is hereby made to that certain letter agreement by and between you and Accretive Health, Inc. (the “Company”) dated April 27,
2013 (the “Letter Agreement”). The Letter Agreement is hereby amended in accordance with Section 17 of the Letter Agreement as set forth herein (this “Amendment”), and to the extent that there is any conflict
between the terms and conditions of this Amendment and the terms and conditions of the Letter Agreement, the terms and conditions of this Amendment will govern and prevail. Capitalized terms used herein, but not otherwise defined, will have the
meanings attributed to such terms in the Letter Agreement. Except as specifically provided herein, the Letter Agreement will remain in full force and effect in accordance with all of the terms and conditions thereof. 

Relocation. Your primary work location with the Company will be in Chicago, Illinois, and you will promptly relocate to the Chicago,
Illinois metropolitan area. You will be entitled to relocation benefits commensurate with your position in accordance with the Company’s relocation program as in effect from time to time. In addition, upon presentation of appropriate written
documentation, the Company will reimburse you during your employment with the Company for (a) monthly housing expenses incurred by you in the Chicago, Illinois metropolitan area from the date hereof through the second anniversary of the date
hereof, up to a maximum of $6,000 per month, and (b) the cost of a one-time education consultant, up to a maximum of $2,000. Finally, the Company will arrange for the purchase of your current residence in Dallas, Texas in accordance with the
Company’s “Guaranteed Offer Program” with OneSource. 
 Monthly Supplemental Cash Retention Bonus. During the period of
your employment with the Company, you will be entitled to receive a monthly supplemental retention bonus in the amount of $25,000, payable in cash on a monthly basis in arrears on the last business day of each calendar month. 

One-Time Cash Retention Bonus. You will receive an aggregate cash retention bonus in an amount equal to $1,700,000 (the
“Retention Bonus”), payable on the second anniversary of the date of this Amendment, subject to your continued employment with the Company on such anniversary. Notwithstanding the foregoing, in the event that your employment with
the Company terminates as a result of a termination by the Company without Cause or by you for Good Reason at any time prior to payment of the Retention Bonus, the Retention Bonus will be paid to you in a single cash lump sum within sixty
(60) days 

 
following the date of such termination, subject to the provisions of Section 10(c) of the Letter Agreement. In addition, upon the occurrence of a Change in Control while you remain in the
continued employment of the Company and prior to payment of the Retention Bonus, 50% of the unpaid the Retention Bonus will be paid to you in a single cash lump sum upon such Change in Control, with the remaining portion of the Retention Bonus to
remain payable in accordance with the preceding two sentences of this paragraph 3. 
 Retention Equity Awards. Contemporaneously with
your execution of this Amendment, you will be granted the following Company equity awards, subject to the approval of the Company’s stockholders of a share reserve increase under its 2010 Stock Incentive Plan on or prior to December 31,
2014 in a sufficient amount to cover such awards: 
 Nonstatutory Stock Option. A nonstatutory stock option to purchase 500,000 shares
of the Company’s common stock to be subject to such terms and conditions as are set forth in a nonstatutory stock option agreement substantially in the form attached hereto as Exhibit A. In the event that the Company’s stockholders
do not approve a share reserve increase under the 2010 Stock Incentive Plan on or prior to December 31, 2014 in a sufficient amount to cover the foregoing contemplated stock option grant, in lieu of such stock option grant, the Company will pay
you cash amounts, at the times provided in the schedule below (collectively, the “Option Replacement Cash Award”), determined by multiplying (i) the excess (if any, or if none, zero) of the per share closing price of the
Company’s common stock on the applicable vesting date set forth in the schedule below (or the immediately preceding trading date if such date is not a trading day) over the per share closing price of the Company’s common stock on
the date of this Amendment, by (ii) the number of shares of common stock that would have become vested on the applicable vesting date set forth in the following schedule had the stock option grant contemplated by this Section 4(a) been
granted on the date of this Amendment without any stockholder approval condition, subject to your continued employment on each applicable vesting date: 
  

					
	 Vesting Date
	  	 Number of

Shares
	  	 Payment Date

	 April 30, 2014, and the last date of each calendar month thereafter through February 29,
2016
	  	20,833	  	The fifteenth (15th) day of the calendar month immediately following the applicable vesting date, except that amounts corresponding to the vesting dates from April 30, 2014 through December 31, 2014 will
be paid on January 15, 2015
			
	 March 31, 2016
	  	20,841	  	April 15, 2016

 Notwithstanding the foregoing, in the event that your employment with the Company terminates as a
result of a termination by the Company without Cause or by you for Good Reason, in either case, at any time prior to payment of the final installment payment contemplated by the foregoing schedule for the Option Replacement Cash Award, any unpaid
portion of the Option Replacement Cash Award as of the date of such termination of employment will be paid to you in a single cash lump sum within sixty (60) days following the date of such termination, subject to the provisions of
Section 10(c) of the Letter Agreement. In addition, in the event of a “Change in Control” (as defined in the Nonstatutory Stock Option Award Agreement by and between you and the Company dated April 27, 2013) while you remain in
the continued employment of the Company and prior to payment of the final installment payment contemplated by the foregoing schedule for the Option Replacement Cash Award, 50% of the unpaid portion of the Option Replacement Cash Award as of the date
of such Change in Control will be paid to you in a single cash lump sum upon such Change in Control, with the remaining portion of the Option Replacement Cash Award to remain payable in accordance with the preceding provisions of this paragraph
4(a), assuming the accelerated portion is applied on a pro rata basis to the remaining installment payments under the Option Replacement Cash Award. 

The amount of the accelerated payments contemplated by the preceding paragraph will be determined by multiplying (x) the excess (if any,
or if none, zero) of the per share closing price of the Company’s common stock on the date of such Change in Control or termination of employment (or the immediately preceding trading date if such date is not a trading day) over the per
share closing price of the Company’s common stock on the date of this Amendment, by (y) the number of shares of common stock in respect of which you would have otherwise remained eligible for a cash payment following the date of such
Change in Control or termination of employment in accordance with the schedule set forth above. 
 For the avoidance of doubt, in the event
that the Company’s stockholders approve a share reserve increase under the 2010 Stock Incentive Plan on or prior to December 31, 2014 in a sufficient amount to cover the stock option grant contemplated by this Section 4(a), all of
your rights with respect to the Option Replacement Cash Award will be null and void and without any legal force or effect whatsoever. 

Restricted Stock. An award of 300,000 restricted shares of the Company’s common stock to be subject to such terms and conditions as
are set forth in a restricted stock award agreement substantially in the form attached hereto as Exhibit B. In the event that the Company’s stockholders do not approve a share reserve increase under the 2010 Stock Incentive Plan on or
prior to December 31, 2014 in a sufficient amount to cover the foregoing contemplated restricted stock award, in lieu of such restricted stock award, the Company will pay you cash amounts, at the times provided in the schedule below
(collectively, the “Restricted Stock Replacement Cash Award”), determined by multiplying (i) the per share closing 

 
price of the Company’s common stock on the applicable vesting date set forth in the schedule below (or the immediately preceding trading date if such date is not a trading day), by
(ii) the number of shares of common stock that would have become vested on the applicable vesting date set forth in the following schedule had the restricted stock award contemplated by this Section 4(b) been granted on the date of this
Amendment without any stockholder approval condition, subject to your continued employment on each applicable vesting date: 
  

					
	 Vesting Date
	  	 Number of

Shares
	  	 Payment Date

	 April 30, 2014, and the last date of each calendar month thereafter through March 31,
2016
	  	12,500	  	The fifteenth (15th) day of the calendar month immediately following the applicable vesting date, except that amounts corresponding to the vesting dates from April 30, 2014 through December 31, 2014 will
be paid on January 15, 2015

 Notwithstanding the foregoing, in the event that your employment with the Company terminates as a result of a
termination by the Company without Cause or by you for Good Reason, in either case, at any time prior to payment of the final installment payment contemplated by the foregoing schedule for the Restricted Stock Replacement Cash Award, any unpaid
portion of the Restricted Stock Replacement Cash Award as of the date of such termination of employment will be paid to you in a single cash lump sum within sixty (60) days following the date of such termination, subject to the provisions of
Section 10(c) of the Letter Agreement. In addition, in the event of a “Change in Control” (as defined in the Restricted Stock Award Agreement by and between you and the Company dated April 27, 2013) while you remain in the
continued employment of the Company and prior to payment of the final installment payment contemplated by the foregoing schedule for the Restricted Stock Replacement Cash Award, 50% of the unpaid portion of the Restricted Stock Replacement Cash
Award as of the date of such Change in Control will be paid to you in a single cash lump sum upon such Change in Control, with the remaining portion of the Restricted Stock Replacement Cash Award to remain payable in accordance with the preceding
provisions of this paragraph 4(b), assuming the accelerated portion is applied on a pro rata basis to the remaining installment payments under the Restricted Stock Replacement Cash Award. 

The amount of the accelerated payments contemplated by the preceding paragraph will be determined by multiplying (x) the per share closing
price of the Company’s common stock on the date of such Change in Control or termination of employment (or the immediately preceding trading date if such date is not a trading day), by (y) the number of shares of common stock in respect of
which you would have otherwise remained eligible for a cash payment following the date of such Change in Control or termination of employment in accordance with the schedule set forth above. 

 For the avoidance of doubt, in the event that the Company’s stockholders approve a share
reserve increase under the 2010 Stock Incentive Plan on or prior to December 31, 2014 in a sufficient amount to cover the restricted stock award contemplated by this Section 4(b), all of your rights with respect to the Restricted Stock
Replacement Cash Award will be null and void and without any legal force or effect whatsoever. 
 Extension of Post-Termination Exercise
Period under Sign-On Stock Option. Pursuant to Section 7(a) of the Letter Agreement, you were granted a nonstatutory option to purchase 800,000 shares of the Company’s common stock under a Nonstatutory Stock Option Award Agreement
dated April 27, 2013. Notwithstanding any other provision in such Nonstatutory Stock Option Award Agreement to the contrary, in the event of your termination of employment by the Company without Cause or by you for Good Reason at any time, the
vested portion of such nonstatutory stock option as of the date of such termination will remain exercisable for a period equal to sixty (60) days following the date of such termination, plus such additional period that corresponds to the
period of your employment with the Company following the date of this Amendment (but in no event beyond the earlier of two (2) years following the date of such termination and the maximum stated term of the stock option under the award
agreement). 
 Professional Fees. Upon presentation of appropriate documentation, the Company will pay or reimburse you for your
reasonable counsel fees incurred in connection with the negotiation and documentation of this Amendment, up to a maximum of $50,000 which will be paid within sixty (60) days following the date hereof. 

[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK] 

 This Amendment is intended to be a binding obligation on you and the Company. If this Amendment accurately
reflects your understanding of your new compensation arrangements with the Company, please sign and date one copy of this Amendment and return the same to us for the Company’s records. You should make a copy of the executed Amendment for your
records. 
  

	
	Very truly yours,
	
	 /s/ Daniel Zaccardo

	Daniel A. Zaccardo
	Senior Vice President, General Counsel and Corporate Secretary

 The above terms and conditions accurately reflect our understanding regarding the terms and conditions of this Amendment, and
I hereby confirm my agreement to the same. 
  

					
	Dated: April 29, 2014	 	 /s/ Joseph Flanagan

		 	Joseph Flanagan

 Signature Page - Amendment to Joseph Flanagan Offer Letter Agreement 

 EXHIBIT A 

NONSTATUTORY STOCK OPTION AWARD AGREEMENT 

 EXHIBIT B 

RESTRICTED STOCK AWARD AGREEMENT

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00239-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00239-of-00352.parquet"}]]